Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

HSPC152 Inhibitors

HSPC152 inhibitors are a class of small molecules that selectively target the HSPC152 protein, which is also known as PGAM5 (phosphoglycerate mutase family member 5). These inhibitors typically interact with the catalytic or regulatory domains of HSPC152 to modulate its activity, either through direct binding or by altering its conformation. HSPC152 is a mitochondrial protein with a dual role in regulating both phosphatase and kinase activities, particularly influencing mitochondrial dynamics and apoptosis. The inhibitors of HSPC152 are often designed to disrupt its function in cellular signaling pathways, particularly those involved in processes such as cell survival, mitochondrial fission, and apoptosis regulation. Structurally, these inhibitors vary widely but usually feature specific chemical scaffolds capable of engaging the active site or relevant domains of the HSPC152 protein, often with high specificity and affinity.

The design of HSPC152 inhibitors requires careful consideration of molecular interactions, particularly because the protein is located within the mitochondria and has a key role in maintaining mitochondrial function and homeostasis. Inhibitors often have to demonstrate mitochondrial permeability to effectively reach their target site. Additionally, they are structured to interact with the protein's key functional motifs without disrupting other cellular processes, as HSPC152 is involved in numerous signaling pathways. The binding of these inhibitors to HSPC152 can lead to alterations in mitochondrial membrane potential and impact processes like cell division and programmed cell death. Understanding the binding mechanisms, chemical modifications to improve specificity, and the bioavailability of HSPC152 inhibitors is crucial for exploring their role in regulating mitochondrial function and protein interactions. The research into the structural features and activity of these inhibitors remains an area of growing interest for biochemical and cellular studies focused on mitochondrial regulation.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D may inhibit TRMT11-2 expression by interfering with RNA polymerase activity, leading to decreased transcription of TRMT11-2 mRNA.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Cycloheximide could inhibit TRMT11-2 expression by blocking protein synthesis, thereby preventing the translation of TRMT11-2 mRNA into protein.

Puromycin dihydrochloride

58-58-2sc-108071
sc-108071B
sc-108071C
sc-108071A
25 mg
250 mg
1 g
50 mg
$40.00
$210.00
$816.00
$65.00
394
(15)

Puromycin might inhibit TRMT11-2 expression by prematurely terminating protein synthesis, leading to the degradation of partially translated TRMT11-2 mRNA.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$97.00
$254.00
36
(2)

Anisomycin may inhibit TRMT11-2 expression by blocking protein synthesis, similar to Cycloheximide, thus preventing the translation of TRMT11-2 mRNA.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$95.00
$322.00
$663.00
$1438.00
6
(1)

Rifampicin might inhibit TRMT11-2 expression by targeting bacterial RNA polymerase, which shares structural similarities with eukaryotic RNA polymerase, leading to decreased transcription of TRMT11-2 mRNA.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

Alpha-Amanitin may inhibit TRMT11-2 expression by blocking RNA polymerase II activity, which is responsible for transcribing TRMT11-2 mRNA, thus preventing its synthesis.

Emetine

483-18-1sc-470668
sc-470668A
sc-470668B
sc-470668C
1 mg
10 mg
50 mg
100 mg
$352.00
$566.00
$1331.00
$2453.00
(0)

Emetine could inhibit TRMT11-2 expression by blocking protein synthesis, similar to Cycloheximide and Anisomycin, leading to the degradation of partially translated TRMT11-2 mRNA.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$169.00
$299.00
66
(3)

Tunicamycin might inhibit TRMT11-2 expression by interfering with protein glycosylation, which is necessary for the proper folding and stability of newly synthesized TRMT11-2 protein.

Blasticidin S Hydrochloride

3513-03-9sc-204655A
sc-204655
25 mg
100 mg
$360.00
$475.00
20
(2)

Blasticidin S could inhibit TRMT11-2 expression by causing premature termination of protein synthesis, leading to the degradation of partially translated TRMT11-2 mRNA.